US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Faeth Therapeutics

38.72

+2.607.20%

Volume:66.03K

Turnover:2.48M

Market Cap:998.16M

PE:-0.27

High:39.24

Open:35.31

Low:34.79

Close:36.12

52wk High:42.14

52wk Low:7.45

Shares:25.78M

Float Shares:811.70K

Volume Ratio:1.22

T/O Rate:8.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-141.6499

EPS(LYR):-16.7239

ROE:-195.26%

ROA:-20.79%

PB:5.77

PE(LYR):-2.32

Loading ...

Overview Company News Filings

Faeth Therapeutics Grants New-hire Stock Options for 25,500 Shares at $28.19 Each

Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Faeth Therapeutics Initiated at Market Outperform by Citizens

Faeth Therapeutics Price Target Maintained with a $55.00/share by BTIG

Faeth Therapeutics, Inc trading halted, volatility trading pause

NASDAQ Trade Halt Volatility Trading Pause at 03:31 Pm

Faeth Therapeutics Grants New-hire Inducement Stock Options for 180,350 Shares

Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Faeth Therapeutics (FTH) and Arcturus Therapeutics (ARCT)

Faeth Therapeutics CFO Brian C. Stephenson Acquires USD 319,293 of Common Shares

Faeth Therapeutics CFO Makes Bold Insider Move With Fresh Share Purchase

Faeth Therapeutics CFO Brian C. Stephenson Reports $489,159 Common Share Purchase

Faeth Therapeutics Initiated at Outperform by Baird

Baird Initiates Faeth Therapeutics at Outperform With $57 Price Target

MT Newswires Live

U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex

Faeth Therapeutics initiated with an Outperform at Baird

Top Faeth Therapeutics Insiders Quietly Double Down on the Company’s Future

Faeth Therapeutics CEO Anand Kiran Parikh Acquires $55,458.56 in Common Shares

Faeth Therapeutics CFO Brian C. Stephenson files initial beneficial ownership statement

Faeth Therapeutics Initiated at Buy by HC Wainwright & Co.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/FTH/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":38.72,"timestamp":1789051192950,"preClose":36.12,"halted":0,"volume":66032,"delay":0,"changeRate":0.07198228128460692,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"Trading","change":2.6,"latestTime":"09-10 10:40:00 EDT","open":35.31,"high":39.24,"low":34.79,"amount":2475658.20744,"amplitude":0.1232,"askPrice":38.85,"askSize":100,"bidPrice":38.43,"bidSize":110,"shortable":3,"etf":0,"ttmEps":-141.6499,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789070400000},"marketStatusCode":2,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":36.12,"preHourTrading":{"tag":"盘前","latestPrice":36.12,"preClose":36.12,"latestTime":"09:17 EDT","volume":15,"amount":541.8,"timestamp":1789046244849,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":35.5,"preClose":36.12,"latestTime":"19:30 EDT","volume":2759,"amount":98405.76,"timestamp":1788996605668,"change":-0.62,"changeRate":-0.017165,"amplitude":0.017165},"volumeRatio":1.218667},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":1.218667,"shares":25778800,"dividePrice":0,"high":39.24,"amplitude":0.1232,"preClose":36.12,"low":34.79,"week52Low":7.45,"pbRate":"5.77","week52High":42.1431,"institutionHeld":0,"latestPrice":38.72,"committee":0.047619,"eps":-141.6499,"divideRate":0,"volume":66032,"delay":0,"ttmEps":-141.6499,"open":35.31,"prevYearClose":10.67,"prevWeekClose":40.05,"prevMonthClose":32.77,"prevQuarterClose":25,"fiveDayClose":39.12,"twentyDayClose":29.38,"sixtyDayClose":13.85},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.5833,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5833,"analysts":12,"updateTime":1787371200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-09-09","current":-0.27335,"percent":0.017857,"low":-5.292894,"twenty":-4.469555,"median":-3.964715,"eighty":-3.355686,"high":-0.105707,"avg":-3.767655,"sd":1.139125,"marketCap":1012944660},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642},{"date":"2026-08-28","current":-4.458983,"twenty":-4.358015,"median":-3.881185,"eighty":-3.294301,"marketCap":871855939},{"date":"2026-09-04","current":-5.154129,"twenty":-4.410264,"median":-3.939688,"eighty":-3.344613,"marketCap":1007776575},{"date":"2026-09-09","current":-5.180561,"twenty":-4.469555,"median":-3.964715,"eighty":-3.355686,"marketCap":1012944660}],"updateTime":1789051200793},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2653277385","title":"Faeth Therapeutics Grants New-hire Stock Options for 25,500 Shares at $28.19 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2653277385","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653277385?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:00","pubTimestamp":1784836826,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics grants new-hire stock options for 25,500 shares at $28.19 eachFaeth Therapeutics granted new-hire stock options covering 25,500 shares under its 2026 Inducement Plan, effective July","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL7yQWcp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653780757","title":"Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2653780757","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653780757?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:00","pubTimestamp":1784836801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nTUA1Z0W9D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652722216","title":"Faeth Therapeutics Initiated at Market Outperform by Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2652722216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652722216?lang=en_us&edition=fundamental","pubTime":"2026-07-20 21:32","pubTimestamp":1784554320,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings(END) Dow Jones NewswiresJuly 20, 2026 09:32 ET","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651443996","title":"Faeth Therapeutics Price Target Maintained with a $55.00/share by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2651443996","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651443996?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:07","pubTimestamp":1784196420,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings(END) Dow Jones NewswiresJuly 16, 2026 06:07 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651493200","title":"Faeth Therapeutics, Inc trading halted, volatility trading pause","url":"https://stock-news.laohu8.com/highlight/detail?id=2651493200","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651493200?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:35","pubTimestamp":1784144129,"startTime":"0","endTime":"0","summary":"15:31 EDT Faeth Therapeutics (FTH), Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-inc-trading-halted-volatility-trading-pause-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","QQQP","FTH","JULD","RSEE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651931964","title":"NASDAQ Trade Halt Volatility Trading Pause at 03:31 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2651931964","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651931964?lang=en_us&edition=fundamental","pubTime":"2026-07-16 03:31","pubTimestamp":1784143871,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 03:31 PM","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260715:nAQN2M86CZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648799660","title":"Faeth Therapeutics Grants New-hire Inducement Stock Options for 180,350 Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648799660","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648799660?lang=en_us&edition=fundamental","pubTime":"2026-07-04 04:00","pubTimestamp":1783108814,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics grants new-hire inducement stock options for 180,350 sharesFaeth Therapeutics issued stock options for 180,350 shares under its 2026 Inducement Plan for six newly hired employees.15","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nNDL4R2wRc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648402660","title":"Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648402660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648402660?lang=en_us&edition=fundamental","pubTime":"2026-07-04 04:00","pubTimestamp":1783108800,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nTUA41C3ND:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648681913","title":"Analysts Offer Insights on Healthcare Companies: Faeth Therapeutics (FTH) and Arcturus Therapeutics (ARCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2648681913","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648681913?lang=en_us&edition=fundamental","pubTime":"2026-07-03 00:10","pubTimestamp":1783008609,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Faeth Therapeutics (FTH) and Arcturus Therapeutics (...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-faeth-therapeutics-fth-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-faeth-therapeutics-fth-and-arcturus-therapeutics-arct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","HCSG","BK4139","LU0128526141.USD","BK4585","BK4137","LABU","ARCT","BK4581","FTH","BK4588","XLV","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648527330","title":"Faeth Therapeutics CFO Brian C. Stephenson Acquires USD 319,293 of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2648527330","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648527330?lang=en_us&edition=fundamental","pubTime":"2026-07-02 08:10","pubTimestamp":1782951030,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics CFO Brian C. Stephenson acquires USD 319,293 of common sharesFaeth Therapeutics CFO Brian C. Stephenson disclosed open-market purchases of 13,634 common shares at prices around $22.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDL6sXCX7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Faeth Therapeutics CFO Brian C. Stephenson Acquires USD 319,293 of Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646339930","title":"Faeth Therapeutics CFO Makes Bold Insider Move With Fresh Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2646339930","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646339930?lang=en_us&edition=fundamental","pubTime":"2026-06-27 10:02","pubTimestamp":1782525737,"startTime":"0","endTime":"0","summary":"New insider activity at Faeth Therapeutics ( ($FTH) ) has taken place on June 26, 2026. Faeth Therapeutics has seen a notable insider move as CFO B...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/faeth-therapeutics-cfo-makes-bold-insider-move-with-fresh-share-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/faeth-therapeutics-cfo-makes-bold-insider-move-with-fresh-share-purchase-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646239597","title":"Faeth Therapeutics CFO Brian C. Stephenson Reports $489,159 Common Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2646239597","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646239597?lang=en_us&edition=fundamental","pubTime":"2026-06-27 07:41","pubTimestamp":1782517266,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics CFO Brian C. Stephenson reports $489,159 common share purchaseFaeth Therapeutics CFO Brian C. Stephenson reported open-market purchases of 18,641 common shares held indirectly.Price","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL7zndP1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Faeth Therapeutics CFO Brian C. Stephenson Reports $489,159 Common Share Purchase","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646935147","title":"Faeth Therapeutics Initiated at Outperform by Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2646935147","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646935147?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:17","pubTimestamp":1782472620,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings(END) Dow Jones NewswiresJune 26, 2026 07:17 ET","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646356378","title":"Baird Initiates Faeth Therapeutics at Outperform With $57 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2646356378","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646356378?lang=en_us&edition=fundamental","pubTime":"2026-06-26 18:07","pubTimestamp":1782468465,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics (FTHM) has an average rating of buy and mean price target of $54.40, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646133434","title":"U.S. Research Roundup-american Tower, H.B. Fuller Company, TD Synnex","url":"https://stock-news.laohu8.com/highlight/detail?id=2646133434","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646133434?lang=en_us&edition=fundamental","pubTime":"2026-06-26 15:06","pubTimestamp":1782457590,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-American Tower, H.B. Fuller Company, TD SynnexJune 26 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, includin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nL4N42Y0ET:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AR","CUZ","ESTC","AMH","ALGT","A","CSX","ACA","LU0648001328.SGD","AVXX","GH","AMT","EPR","ESS","CMC","LU0477156953.USD","CNTB","EXPD","BRO","ALLY","AMAT","LU2413666699.HKD","SNX","CALY","CTSH","TECH","DRI","DYN","LU0011850046.USD","FTH","LU0347712357.USD","BHVN","IE00BD4GTW91.USD","AAL","BNED","ACNB","DAL","BNY","AVTR","FDXF","GOLF","AIT","BDC","AALG","CROX","BAC","ALK","AVAV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646225385","title":"Faeth Therapeutics initiated with an Outperform at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2646225385","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646225385?lang=en_us&edition=fundamental","pubTime":"2026-06-26 04:21","pubTimestamp":1782418864,"startTime":"0","endTime":"0","summary":"Baird analyst Jack Allen initiated coverage of Faeth Therapeutics (FTH) with an Outperform rating and $57 price target Faeth is built around Piktor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-an-outperform-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-an-outperform-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646238648","title":"Top Faeth Therapeutics Insiders Quietly Double Down on the Company’s Future","url":"https://stock-news.laohu8.com/highlight/detail?id=2646238648","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646238648?lang=en_us&edition=fundamental","pubTime":"2026-06-25 10:03","pubTimestamp":1782353016,"startTime":"0","endTime":"0","summary":"New insider activity at Faeth Therapeutics ( ($FTH) ) has taken place on June 24, 2026. Faeth Therapeutics has seen notable insider buying activity...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-faeth-therapeutics-insiders-quietly-double-down-on-the-companys-future-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-faeth-therapeutics-insiders-quietly-double-down-on-the-companys-future-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646603844","title":"Faeth Therapeutics CEO Anand Kiran Parikh Acquires $55,458.56 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2646603844","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646603844?lang=en_us&edition=fundamental","pubTime":"2026-06-25 06:56","pubTimestamp":1782341762,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics CEO Anand Kiran Parikh acquires $55,458.56 in common sharesFaeth Therapeutics President and CEO Anand Kiran Parikh reported an increase in his direct common stock stake to 817,699 s","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260624:nNDL8grlyV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Faeth Therapeutics CEO Anand Kiran Parikh Acquires $55,458.56 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645465854","title":"Faeth Therapeutics CFO Brian C. Stephenson files initial beneficial ownership statement","url":"https://stock-news.laohu8.com/highlight/detail?id=2645465854","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645465854?lang=en_us&edition=fundamental","pubTime":"2026-06-24 05:22","pubTimestamp":1782249758,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics CFO Brian C. Stephenson filed an initial ownership report showing a stock option for 166,435 shares at $29.37, expiring March 10, 2036.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Faeth Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260623:nNDL9TNMfC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645029082","title":"Faeth Therapeutics Initiated at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2645029082","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645029082?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:14","pubTimestamp":1782126840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 22, 2026 07:14 ET (11:14 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":83,"code":"91000000","status":"200"}]}}